Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.500
+0.030 (1.21%)
Nov 21, 2024, 4:00 PM EST - Market closed
Mangoceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -9.33 | -9.21 | -2 | -0.07 |
| Depreciation & Amortization | 0.02 | 0.02 | 0 | - |
| Stock-Based Compensation | 2.67 | 2.16 | 0.77 | - |
| Other Operating Activities | 0.51 | -0.01 | -0.15 | 0 |
| Change in Inventory | 0.01 | -0.02 | - | - |
| Change in Accounts Payable | 0.66 | 0.11 | 0.03 | - |
| Change in Other Net Operating Assets | 0.01 | -0.05 | -0.01 | - |
| Operating Cash Flow | -5.43 | -7 | -1.35 | -0.07 |
| Capital Expenditures | - | -0 | -0.04 | - |
| Investing Cash Flow | 0.07 | -0 | -0.04 | - |
| Short-Term Debt Issued | - | - | 0.08 | - |
| Total Debt Issued | 0.19 | - | 0.08 | 0.16 |
| Short-Term Debt Repaid | - | -0.17 | -0.03 | - |
| Total Debt Repaid | - | -0.17 | -0.03 | - |
| Net Debt Issued (Repaid) | 0.19 | -0.17 | 0.05 | 0.16 |
| Issuance of Common Stock | 1.77 | 7.22 | 2 | 0 |
| Financing Cash Flow | 4.21 | 7.06 | 2.05 | 0.16 |
| Net Cash Flow | -1.16 | 0.06 | 0.66 | 0.09 |
| Free Cash Flow | -5.43 | -7 | -1.39 | -0.07 |
| Free Cash Flow Margin | -719.46% | -957.07% | -15545.59% | - |
| Free Cash Flow Per Share | -3.29 | -6.52 | -1.93 | -0.13 |
| Levered Free Cash Flow | -1.63 | -2.85 | -0.49 | - |
| Unlevered Free Cash Flow | -1.34 | -2.85 | -0.49 | - |
| Change in Net Working Capital | -1.13 | -0.04 | -0.02 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.